Oral health related quality of life in oral submucous fibrosis patients using OHIP tool
An original research
Keywords:
oral cancer, oral health, oral submucous fibrosis, patients, quality lifeAbstract
The objective of the present study was to assess the oral-health-related quality of life (OHRQoL) of oral submucous fibrosis (OSMF) patients. A convenient sampling technique was used to recruit the clinically diagnosed patients of OSMF (n = 50). Based on the medical treatment, the patients were randomly divided into two study groups (group A and B). The group A patients received hyaluronidase (1500 IU) and Group B patients received submucosal intralesional injections of dexamethasone (2 mL; 4 gm/mL). Both the group A and B patients received respective medical therapy biweekly for a period of ten weeks. At the follow up visit (3 months), the impact of treatment on OHRQoL was assessed using the Oral Health Impact Profile-14(OHIP-14). Data were analyzed by a chi-square test for quantitative variables and an independent t-test for qualitative variables. The comparison of all clinical parameters before and after treatment was performed by a paired t-test. The results after treatment showed that there was a significant improvement in all domains of OHIP-14 except psychological disability. In addition, the OHRQoL of patients was significantly improved following the treatment.
Downloads
References
Bennadi, D.; Reddy, C. Oral health related quality of life. J. Int. Soc. Prev. Community Dent. 2013, 3, 1–6. [CrossRef] [PubMed]
Sischo, L.; Broder, H. Oral health-related quality of life: What, why, how, and future implications. J. Dent. Res. 2011, 90, 1264–1270. [CrossRef]
Olsson, I.N.; Runnamo, R.; Engfeldt, P. Medication quality and quality of life in the elderly, a cohort study. Health Qual. Life Outcomes 2011, 9, 95. [CrossRef]
Prabhu, N.; Rao, S.S.; Kotrashetti, S.M.; Baliga, S.D.; Hallikerimath, S.R.; Angadi, P.V.; Issrani, R. Pentoxifylline in patients with oral submucous fibrosis-a randomized clinical trial. J. Maxillofac. Oral Surg. 2015, 14, 81–89. [CrossRef] [PubMed]
Veedu, R.A.; Balan, A. A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015, 120, 588–593. [CrossRef] [PubMed]
Slade, G.D. Derivation and validation of a short-form oral health impact profile. Community Dent. Oral. Epidemiol. 1997, 25,284–290. [CrossRef]
Ffrooz, A.; Tehranchia-Nia, Z.; Ahmed, A. Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin. Exp. Dermatol. 1995, 20, 363–370. [CrossRef]
Canniff, J.; Harvey,W. The aetiology of oral submucous fibrosis: The stimulation of collagen synthesis by extracts of areca nut. Int. J. Oral Surg. 1981, 10 (Suppl. S1), 163–167.
Shah, N.; Sharma, P. Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): A case-control study. J. Oral Pathol. Med. 1998, 27, 475–479. [CrossRef]
Mishra, G.; Ranganathan, K. An overview of classification schemes for oral submucous fibrosis. J. Oral Maxillofac. Pathol. 2006, 10, 55–59.
Bhonsle, R.; Murti, P.R.; Pindborg, J.J.; Daftary, D.K.; Mehta, F.S. Focal vascular dilatations and petechiae in oral submucous fibrosis. Eur. J. Oral Sci. 1981, 89, 270–274. [CrossRef] [PubMed]
Canniff, J.; Harvey,W.; Harris, M. Oral submucous fibrosis: Its pathogenesis and management. Br. Dent. J. 1 1986, 160, 429–434. [CrossRef]
Imam, S.Z.; Nawaz, H.; Sepah, Y.J.; Pabaney, A.H.; Ilyas, M.; Ghaffar, S. Use of smokeless tobacco among groups of Pakistani medical students–a cross sectional study. BMC Public Health 2007, 7, 231. [CrossRef]
Mahmood, Z. Smoking and chewing habits of people of Karachi–1981. J. Pak Med. Assoc. 1982, 32, 34–37.
Shear, M.; Lemmer, J.; Dockrat, I. Oral submucous fibrosis in South African Indians: An epidemiological study. South Afr. Med. J. 1967, 32, 41–46.
Van Wyk, C.; Seedat, H.; Phillips, V. Collagen in submucous fibrosis: An electron-microscopic study. J. Oral Pathol. Med. 1990, 19, 182–187. [PubMed]
Bathi, R.J.; Parveen, S.; Burde, K. The role of gutka chewing in oral submucous fibrosis: A case-control study. Quintessence Int. 2009, 40, e19–e25.
Pindborg, J.; Zachariah, J. Frequency of oral submucous fibrosis among 100 South Indians with oral cancer. Bull. World Health Organ. 1965, 32, 750.
Agrawal, A.; Chandel, S.; Singh, N.; Singhal, A. Use of tobacco and oral sub mucous fibrosis in teenagers. J. Dent. Sci. Res. 2012, 3, 1–4.
Shahid, H.; Qadri, M.; Hassan, S. Oral submucous fibrosis; oral health impact profile of patients and its correlation with its clinical grading. Prof. Med. J. 2017, 24, 1719–1726.
Rimal, J.; Shrestha, A. Validation of Nepalese Oral Health Impact Profile14 and Assessment of Its Impact in Patients with Oral Submucous Fibrosis in Nepal. J. Nepal. Health Res. Counc. 2015, 13, 43–49. [PubMed]
Passi, D.; Bhanot, P.; Kacker, D.; Chahal, D.; Atri, M.; Panwar, Y. Oral submucous fibrosis: Newer proposed classification with c Aziz, S.R. Oral submucous fibrosis: Case report and review of diagnosis and treatment. J. Oral Maxillofac. Surg. 2008, 66, 2386–2389. [CrossRef] [PubMed]
Nair, D.R.; Pruthy, R.; Pawar, U.; Chaturvedi, P. Oral cancer: Premalignant conditions and screening—An update. J. Cancer Res.
Therpeutics 2012, 8, 57–66.ritical updates in pathogenesis and management strategies. Natl. J. Maxillofac. Surg. 2017, 8, 89–94. [CrossRef] [PubMed]
Patil, P.G.; Hazarey, V.; Chaudhari, R.; Nimbalkar-Patil, S. A randomized control trial measuring the effectiveness of a mouthexercising device for mucosal burning in oral submucous fibrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016, 122, 713–718.
[CrossRef]
Tanwir, F.; Akhlaq, H. Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran. J. Pathol. 2011, 6, 165–172.
Patil, P.; Hazarey, V.; Chaudhari, R.; Nimbalkar-Patil, S. Clinical Efficacy of a Mouth-Exercising Device Adjunct to Local Ointment, Intra-Lesional Injections and Surgical Treatment for Oral Submucous Fibrosis: A Randomized Controlled Trial. Asian Pac. J. Cancer Prev. 2016, 17, 1255–1259. [CrossRef]
Regezi, J.; Sciubba, J.; Jordan, R. Oral Pathology: Clinical Pathologic Correlations; Dolan, J., Ed.; Elsevier: Amsterdam, The Netherlands, 2016.
Khan, S.; Prashanth, S.K.; Rao, P.K.; Chatra, L.; Veena, K.M. Pathogenesis of oral submucous fibrosis. J. Cancer Res. Ther. 2012, 8, 199. [CrossRef]
Shih, Y.H.; Wang, T.-H.; Shieh, T.-M.; Tseng, Y.-H. Oral submucous fibrosis: A review on etiopathogenesis, diagnosis, and therapy. Int. J. Mol. Sci. 2019, 20, 2940. [CrossRef]
Tilakaratne, W.; Klinikowski, M.; Saku, T.; Peters, T.; Warnakulasuriya, S. Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol. 2006, 42, 561–568. [CrossRef]
Angadi, P.V.; Rao, S.S. Areca nut in pathogenesis of oral submucous fibrosis: Revisited. Oral Maxillofac. Surg. 2011, 15, 1–9. [CrossRef]
Tak, J.; Gupta, N.; Bali, R. Oral submucous fibrosis: A review article on etiopathogenesis. Kathmandu. Univ. Med. J. 2014, 12, 153–156. [CrossRef]
Gupta, D.; Sharma, S. Oral submucous fibrosis—A new treatment regimen. J. Oral Maxillofac. Surg. 1988, 46, 830–833. [CrossRef]
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
